June 27 (Reuters) - ProMIS Neurosciences Inc PMN.TO :
* PROMIS NEUROSCIENCES' PMN310 SHOWS GREATER THERAPEUTIC POTENTIAL VERSUS. OTHER AMYLOID-BETA-DIRECTED ANTIBODIES
June 27 (Reuters) - ProMIS Neurosciences Inc PMN.TO :
* PROMIS NEUROSCIENCES' PMN310 SHOWS GREATER THERAPEUTIC POTENTIAL VERSUS. OTHER AMYLOID-BETA-DIRECTED ANTIBODIES